Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part III: Clinical and analytical recommendations for the study of monoclonal gammopathies by MALDI-TOF mass spectrometry.

Saved in:
Bibliographic Details
Title: Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part III: Clinical and analytical recommendations for the study of monoclonal gammopathies by MALDI-TOF mass spectrometry.
Authors: Agulló C; Department of Clinical Biochemistry, 37479 Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL) , Salamanca, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., Puig N; Hematology Department, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Instituto de Biología Molecular y Celular del Cáncer (Universidad de Salamanca-Consejo Superior de Investigaciones Científicas), CIBERONC, Salamanca, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain., Varo N; Department of Clinical Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., Iglesias MÁ; Department of Clinical Biochemistry, Hospital 12 de Octubre, Madrid, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., Mugueta C; Department of Clinical Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain., Pello R; Department of Clinical Biochemistry, Hospital 12 de Octubre, Madrid, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., Paiva B; Clínica Universidad de Navarra (CCUN), Centro de Investigación Medica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain., Martínez-López J; Hematology Department, Hospital Universitario 12 de Octubre, Complutense University, i+12, Centro Nacional de Investigaciones Oncológicas, Centro de Investigación Biomédica en Red (CIBERONC), CB16/12/00369, Madrid, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain., Castro S; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Cárdenas MC; Department of Clinical Analysis, Hospital Clinico San Carlos, Madrid, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., García-Sanz R; Hematology and Hemotherapy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Facultad de Medicina, Universidad Complutense de Madrid (UCM), Madrid, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain., Pérez-Surribas D; Laboratori Pasteur, Andorra La Vella, Andorra.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., Flores-Montero J; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain., Ortiz-Espejo M; Department of Clinical Biochemistry, Hospital Universitario Marqués de Valdecilla, Santander, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., de la Rubia J; Hematology Department, University Hospital La Fe and School of Medicine and Dentistry, Catholic University of Valencia; Instituto de Investigación Sanitaria La Fe, València, Spain; CIBERONC CD16/12/00284, Valencia, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain., Cruz-Iglesias E; Department of Clinical Biochemistry, Hospital Universitario de Basurto, Osakidetza, Bilbao, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., Fontán A; Department of Clinical Biochemistry, Hospital Universitario Miguel Servet, Zaragoza, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain., Isidoro-García M; Department of Clinical Biochemistry, University Hospital of Salamanca, Salamanca, Spain.; Medicine Department, University of Salamanca, Salamanca, Spain.; Institute for Biomedical Research of Salamanca, Salamanca, Spain.; Pharmacogenetics and Precision Medicine Unit, Results-Oriented Cooperative Research Networks in Health, Carlos III Health Institute, Madrid, Spain., San-Miguel J; Hematology Department, Cancer Center Clínica Universidad de Navarra (CCUN), CIMA, IDISNA, Pamplona, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain., Mateos MV; Hematology Department, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Instituto de Biología Molecular y Celular del Cáncer (Universidad de Salamanca-Consejo Superior de Investigaciones Científicas), CIBERONC, Salamanca, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain.
Source: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2025 Nov 04; Vol. 64 (3), pp. 586-599. Date of Electronic Publication: 2025 Nov 04 (Print Publication: 2026).
Publication Type: Journal Article; Practice Guideline
Journal Info: Publisher: Walter De Gruyter Country of Publication: Germany NLM ID: 9806306 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1437-4331 (Electronic) Linking ISSN: 14346621 NLM ISO Abbreviation: Clin Chem Lab Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41182012
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part III: Clinical and analytical recommendations for the study of monoclonal gammopathies by MALDI-TOF mass spectrometry.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Agulló+C%22">Agulló C</searchLink>; Department of Clinical Biochemistry, 37479 Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL) , Salamanca, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Puig+N%22">Puig N</searchLink>; Hematology Department, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Instituto de Biología Molecular y Celular del Cáncer (Universidad de Salamanca-Consejo Superior de Investigaciones Científicas), CIBERONC, Salamanca, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Varo+N%22">Varo N</searchLink>; Department of Clinical Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Iglesias+MÁ%22">Iglesias MÁ</searchLink>; Department of Clinical Biochemistry, Hospital 12 de Octubre, Madrid, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Mugueta+C%22">Mugueta C</searchLink>; Department of Clinical Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Pello+R%22">Pello R</searchLink>; Department of Clinical Biochemistry, Hospital 12 de Octubre, Madrid, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Paiva+B%22">Paiva B</searchLink>; Clínica Universidad de Navarra (CCUN), Centro de Investigación Medica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez-López+J%22">Martínez-López J</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Complutense University, i+12, Centro Nacional de Investigaciones Oncológicas, Centro de Investigación Biomédica en Red (CIBERONC), CB16/12/00369, Madrid, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Castro+S%22">Castro S</searchLink>; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Cárdenas+MC%22">Cárdenas MC</searchLink>; Department of Clinical Analysis, Hospital Clinico San Carlos, Madrid, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22García-Sanz+R%22">García-Sanz R</searchLink>; Hematology and Hemotherapy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Facultad de Medicina, Universidad Complutense de Madrid (UCM), Madrid, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pérez-Surribas+D%22">Pérez-Surribas D</searchLink>; Laboratori Pasteur, Andorra La Vella, Andorra.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Flores-Montero+J%22">Flores-Montero J</searchLink>; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Ortiz-Espejo+M%22">Ortiz-Espejo M</searchLink>; Department of Clinical Biochemistry, Hospital Universitario Marqués de Valdecilla, Santander, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22de+la+Rubia+J%22">de la Rubia J</searchLink>; Hematology Department, University Hospital La Fe and School of Medicine and Dentistry, Catholic University of Valencia; Instituto de Investigación Sanitaria La Fe, València, Spain; CIBERONC CD16/12/00284, Valencia, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Cruz-Iglesias+E%22">Cruz-Iglesias E</searchLink>; Department of Clinical Biochemistry, Hospital Universitario de Basurto, Osakidetza, Bilbao, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Fontán+A%22">Fontán A</searchLink>; Department of Clinical Biochemistry, Hospital Universitario Miguel Servet, Zaragoza, Spain.; Protein Biomarkers Commission, Spanish Society of Laboratory Medicine (SEMEDLAB), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Isidoro-García+M%22">Isidoro-García M</searchLink>; Department of Clinical Biochemistry, University Hospital of Salamanca, Salamanca, Spain.; Medicine Department, University of Salamanca, Salamanca, Spain.; Institute for Biomedical Research of Salamanca, Salamanca, Spain.; Pharmacogenetics and Precision Medicine Unit, Results-Oriented Cooperative Research Networks in Health, Carlos III Health Institute, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22San-Miguel+J%22">San-Miguel J</searchLink>; Hematology Department, Cancer Center Clínica Universidad de Navarra (CCUN), CIMA, IDISNA, Pamplona, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Mateos+MV%22">Mateos MV</searchLink>; Hematology Department, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Instituto de Biología Molecular y Celular del Cáncer (Universidad de Salamanca-Consejo Superior de Investigaciones Científicas), CIBERONC, Salamanca, Spain.; Spanish Society of Hematology and Hemotherapy (SEHH), Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229806306%22">Clinical chemistry and laboratory medicine</searchLink> [Clin Chem Lab Med] 2025 Nov 04; Vol. 64 (3), pp. 586-599. <i>Date of Electronic Publication: </i>2025 Nov 04 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Practice Guideline
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Walter+De+Gruyter%22">Walter De Gruyter </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9806306 <i>Publication Model: </i>Electronic-Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1437-4331 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214346621%22">14346621 </searchLink><i>NLM ISO Abbreviation: </i>Clin Chem Lab Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41182012
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1515/cclm-2025-1056
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 586
    Titles:
      – TitleFull: Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part III: Clinical and analytical recommendations for the study of monoclonal gammopathies by MALDI-TOF mass spectrometry.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Agulló C
      – PersonEntity:
          Name:
            NameFull: Puig N
      – PersonEntity:
          Name:
            NameFull: Varo N
      – PersonEntity:
          Name:
            NameFull: Iglesias MÁ
      – PersonEntity:
          Name:
            NameFull: Mugueta C
      – PersonEntity:
          Name:
            NameFull: Pello R
      – PersonEntity:
          Name:
            NameFull: Paiva B
      – PersonEntity:
          Name:
            NameFull: Martínez-López J
      – PersonEntity:
          Name:
            NameFull: Castro S
      – PersonEntity:
          Name:
            NameFull: Cárdenas MC
      – PersonEntity:
          Name:
            NameFull: García-Sanz R
      – PersonEntity:
          Name:
            NameFull: Pérez-Surribas D
      – PersonEntity:
          Name:
            NameFull: Flores-Montero J
      – PersonEntity:
          Name:
            NameFull: Ortiz-Espejo M
      – PersonEntity:
          Name:
            NameFull: de la Rubia J
      – PersonEntity:
          Name:
            NameFull: Cruz-Iglesias E
      – PersonEntity:
          Name:
            NameFull: Fontán A
      – PersonEntity:
          Name:
            NameFull: Isidoro-García M
      – PersonEntity:
          Name:
            NameFull: San-Miguel J
      – PersonEntity:
          Name:
            NameFull: Mateos MV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 11
              Text: 2025 Nov 04
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1437-4331
          Numbering:
            – Type: volume
              Value: 64
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Clinical chemistry and laboratory medicine
              Type: main
ResultId 1